Package 52652-9001-1

{"route": ["ORAL"], "spl_id": "30dc8c36-63cc-07b4-e063-6294a90a9abb", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["2586427", "2586433"], "spl_set_id": ["e2a4df59-fead-4a01-9021-9eda02c48010"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (52652-9001-1)", "package_ndc": "52652-9001-1", "marketing_start_date": "20211206"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (52652-9001-2)  / 240 mL in 1 BOTTLE", "package_ndc": "52652-9001-2", "marketing_start_date": "20230102"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (52652-9001-3)  / 120 mL in 1 BOTTLE", "package_ndc": "52652-9001-3", "marketing_start_date": "20230102"}], "brand_name": "Eprontia", "product_id": "52652-9001_30dc8c36-63cc-07b4-e063-6294a90a9abb", "dosage_form": "SOLUTION", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "52652-9001", "generic_name": "Topiramate", "labeler_name": "Azurity Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eprontia", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/mL"}], "application_number": "NDA214679", "marketing_category": "NDA", "marketing_start_date": "20211206", "listing_expiration_date": "20261231"}